Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults. Preprint

Nav

General Info

Geography

United Kingdom (GBR)

England

Time period covered

01/2020 - 12/2020

Data type

Scientific literature

Keywords

COVID-19, Disease outbreaks

Citation

Authors

Ward H, Atchison CJ, Whitaker M, Ainslie KEC, Elliott J, Okell LC, Redd R, Ashby D, Donnelly CA, Barclay W, Darzi A, Cooke G, Riley S, Elliott P

Journal

medRxiv

Publication year

2020

Suggested citation

Ward H, Atchison CJ, Whitaker M, Ainslie KEC, Elliott J, Okell LC, Redd R, Ashby D, Donnelly CA, Barclay W, Darzi A, Cooke G, Riley S, Elliott P. Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults. Preprint. medRxiv. 2020.

DOI

10.1101/2020.08.12.20173690

GHDx Entry last modified on: Mar 14, 2022

Header sites

Search form

Main menu

Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults. Preprint

Nav